Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMR
· Real-Time Price · USD
4.00
-0.26 (-6.10%)
At close: Aug 15, 2025, 3:59 PM
4.02
0.63%
After-hours: Aug 15, 2025, 07:34 PM EDT
Larimar Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -29.28M | -28.82M | -15.5M | -21.63M | -14.65M | -12.99M | -9.06M | -8.37M | -6.53M | -9.43M | -8.32M | -8.67M | -8.94M | -9.13M | -16.8M | -12.61M | -12.09M |
Depreciation & Amortization | -667K | 77K | 74K | 87K | 80K | 81K | 76K | 76K | 78K | 78K | 77K | 81K | 82K | 88K | 88K | 77K | 73K |
Stock-Based Compensation | 1.83M | 2.41M | 1.96M | 2.3M | 2.13M | 1.92M | 1.82M | 2.04M | 1.83M | 1.64M | 1.67M | 1.68M | 1.64M | 1.48M | 1.46M | 1.35M | 1.18M |
Other Working Capital | n/a | 5.02M | -8.1M | 5.74M | 2.37M | 1.78M | 127K | -2.71M | 991K | 869K | 418K | 1.32M | -964K | -253K | 2.47M | 2.43M | -930K |
Other Non-Cash Items | 1.57M | -1.24M | -1.76M | -682K | 1.37M | 896K | -7K | -27K | -640K | -754K | -63K | -3K | -5K | -2K | -7K | -1K | -5K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.55M | -565K | -29K | n/a | n/a | n/a | n/a | 5K | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 5.76M | -9.32M | 7.07M | 2.66M | 2.31M | -1.46M | -1.06M | -2.3M | 1.79M | 762K | -572K | -307K | -350K | 3.06M | 401K | -366K |
Operating Cash Flow | -26.54M | -21.82M | -24.55M | -13.99M | -10.41M | -9.34M | -9.2M | -7.37M | -7.55M | -6.67M | -5.88M | -7.49M | -7.53M | -7.92M | -12.2M | -10.78M | -11.21M |
Capital Expenditures | -49K | -179K | -62K | -274K | n/a | -164K | n/a | n/a | n/a | n/a | n/a | -100K | n/a | -9K | -293K | -31K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 2.46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -52.5M | -38.62M | -22.67M | -81.72M | -84.86M | -34.97M | -56.42M | -9.85M | n/a | -71.98M | -26.38M | -35.24M | n/a | -1K | -6.5M | n/a | -1.75M |
Sales Maturities Of Investments | 67M | 58M | 50M | 18.5M | 16.5M | 32.5M | 9.99M | 9K | 92.25M | 19.75M | 23M | n/a | n/a | 6.5M | n/a | 19.25M | 7M |
Other Investing Acitivies | n/a | n/a | n/a | -63.22M | -68.36M | -2.46K | -46.43K | -9.84K | 92.25K | -52.23K | -3.38K | -35.24K | n/a | 6.5K | -6.5K | 19.25K | 5.25K |
Investing Cash Flow | 14.45M | 19.2M | 27.27M | -63.49M | -68.36M | -2.63M | -46.43M | -9.84M | 92.25M | -52.23M | -3.38M | -35.34M | n/a | 6.49M | -6.79M | 19.22M | 5.25M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 334K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 30K | 11K | n/a | n/a | 30K | n/a | n/a | n/a | 75.57M | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | 36K | 30K | -334K | 162.15M | n/a | 30K | n/a | n/a | -316K | 75.57M | n/a | n/a | n/a | 19.89M | n/a | n/a |
Net Cash Flow | -12.09M | -2.58M | 4.09M | -77.81M | 83.38M | -11.97M | -55.6M | -17.2M | 84.7M | -59.22M | 66.31M | -42.83M | -7.53M | -1.43M | 895K | 8.44M | -5.96M |
Free Cash Flow | -26.59M | -21.99M | -24.61M | -14.26M | -10.41M | -9.51M | -9.2M | -7.37M | -7.55M | -6.67M | -5.88M | -7.59M | -7.53M | -7.93M | -12.49M | -10.81M | -11.21M |